Analysis of the effectiveness of treatment of patients with acute cerebral disorders by ischemic type with chronic iron-deficient anemia of mild-to-moderate degrees by ferric-containing agent (III). Present treatment has promoted an improvement of both the laboratory and clinical indexes of the patients. By the second week of the treatment one could see a significant increasing of transferrin and ferritin concentration in the blood, and the improvement of the neurological condition — reduction of neurological deficit, improvement of hemodynamic parameters. Subsiding of such pathological symptoms as headache, anorexia, fatigue has been observed. There were no serious adverse effects that could lead to adjustment of the initial dose or drugs’ withdrawal. The result of complex therapy of co-existing diseases was shortening of hospitalization period and outcome improvement.
